Norditropin 48 IU Novo Nordisk

Norditropin is an artificial growth hormone originally intended to be used for medical purposes only. But as often happens, athletes began to use the pharmacological agent over time. Growth hormone was developed for the treatment of children who are experiencing growth retardation, so its composition is as safe as possible for the body. The substance has gained its popularity among athletes. It can be used to increase the overall endurance of the body, increase the intensity of training, and build muscle mass.

Packaging video review Norditropin 48 IU Novo Nordisk

 

The drug has a pronounced effect, due to which it is possible to stimulate the growth of cells and bone tissue. During the course, metabolic processes are significantly accelerated, which is an especially important point for athletes. The preparation contains synthetic somatropin, due to which the content of natural somatotropin is restored. Thanks to what, athletes:

increases muscle mass;
gets rid of adipose tissue;
gets great well-being and extra strength.

The use of growth hormone forces the body’s bone tissue to rebuild, which makes the skeleton more powerful and able to withstand the high loads that a bodybuilder faces. In the first time after the start of the course, weight loss begins, which is associated with the resorption process, after which there is a stable increase. It is possible to determine the appropriate dosage only individually, which depends on the state of the body and how it is able to tolerate the components of the drug.

The main effect of the drug Norditropin NordiLet is to stimulate the growth of the skeleton, muscle mass and a pronounced effect on metabolic processes.

In the treatment of growth hormone deficiency, body proportions are normalized, while muscle mass increases and fat mass decreases.

CONTRAINDICATIONS
any suspicion of the presence of an actively growing malignant tumor. Before starting treatment with growth hormone, it is necessary to make sure that the intracranial tumor is inactive and that anticancer therapy has been completed.

Severe patients with complications after surgery on the heart with an open chest, in the abdominal cavity, multiple trauma, acute respiratory failure, or similar conditions should not be prescribed the drug.

During pregnancy and breastfeeding. Hypersensitivity to any component of the drug.

In children with chronic kidney disease before kidney transplantation, treatment with Norditropin NordiLet 10 mg / 1.5 ml should be discontinued.

SIDE EFFECTS

swelling of the hands and feet due to fluid retention;
redness, itching, and pain at the injection sites;
headache;
pain in muscles and joints;
skin rashes.